B2S Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
- Paid Up Capital ₹ 1.10 M
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.00 M
- Revenue Growth 53.97%
- Profit Growth -1.71%
- Ebitda 1011.03%
- Net Worth 2.82%
- Total Assets 8.98%
About B2S Pharma
B2s Pharma Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 January 2016 (Nine years and one month 20 days old ). Its registered office is in 24 Parganas, West Bengal, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹1.00 M.
Sudipta Das and Sharmila Saha serve as directors at the Company.
Company Details
- Location
24 Parganas, West Bengal, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900WB2016PTC209111
- Company No.
209111
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Who are the key members and board of directors at B2S Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudipta Das  | Director | 05-Jan-2016 | Current |
| Sharmila Saha | Director | 13-Oct-2022 | Current |
Financial Performance of B2S Pharma.
B2S Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53.97% increase. The company also saw a slight decrease in profitability, with a 1.71% decrease in profit. The company's net worth moved up by a moderate rise of 2.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of B2S Pharma?
In 2021, B2S Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Aug 2018 | State Bank Of India | ₹1.00 M | Open |
How Many Employees Work at B2S Pharma?
Unlock and access historical data on people associated with B2S Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of B2S Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped B2S Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
